Cover Image
Market Research Report

Global Pharmaceuticals Industry Analysis and Trends 2023

Published by NAVADHI Market Research Pvt Ltd Product code 799076
Published Content info 339 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Pharmaceuticals Industry Analysis and Trends 2023
Published: March 5, 2019 Content info: 339 Pages
Description

Global pharmaceutical market is expected to grow in the upcoming years despite recent slowdown in key markets across the globe. The reasons are simple: aging and growing population, rising income levels, and emerging medical conditions and emergence of new diseases.

Global pharmaceuticals market is expected to be worth USD 1.57 trillion by 2023.

As per NAVADHI Market Research, the global pharmaceutical industry will we worth USD 1.57 trillion by 2023. The growth in this market is predicted on the basis of various factors like market drivers, current and upcoming trends, current growth pattern, and market challenges.

North America is expected to retain it's leading position in the global pharmaceuticals market with market share of 45.33% in 2023 improving on it's market share compared to 2017. Europe on the contrary is expected to see a decline in it's market share compared to 2017 and be worth 20.24% of global pharma industry in 2023. Asia Pacific pharmaceuticals market is expected to retain it's second position with a market share of 24.07% in 2023. Latin America and Middle East and Africa (MEA) are expected to retain 7.53% and 2.96% market share of global pharmaceuticals market in 2023.

image1

This growth is fuelled by the growing and ageing population in key markets. As per World Population Prospects by United Nations, the worldwide population is likely to cross 9.3 billion by 2050 and around 21% of this population is expected to be aged 60 and above. Apart from ageing and rising population the improvements in purchasing power and access to quality healthcare and pharmaceuticals to poor and middle-class families worldwide also is driving the growth of global pharma industry. Another aspect which is leading this growth is rising focus of pharmaceuticals companies to tap the rare and speciality diseases market. Innovations in advanced biologics, nucleic acid therapeutics, cell therapies and bioelectronics & implantables has attracted investments in the industry by even non-pharma companies like Facebook, Qualcomm etc. which is also driving the global pharmaceuticals industry growth.

On the other hand, adoption of cost control policies along with tightening of rules by governments in key markets are expected to impact the growth prospect of the global pharmaceuticals industry. Pharmaceuticals companies are forced to reduce their research and development (R&D) spending due to slowdown of growth in last few years which is also expected to hamper growth of the global pharma market as new drugs revenue form large part of pharma firm's revenue due to exclusivity of the drug. Apart from this generics pharma market is facing decreasing return on investment due to price erosion in key markets which is forcing many firms to look for other avenues and markets to sustain growth.

image2

Global Pharmaceuticals Industry Analysis and Trends 2023 Market Research Report Coverage

Global Pharmaceuticals Industry Analysis and Trends 2023 report covers growth forecasts for 39 countries along with 5 major geographic regions.

  • 1.In the Asia Pacific region growth forecasts are provided for Australia, China, India, Japan and South Korea.
  • 2.In the Europe region growth forecasts are provided for France, Germany, Italy, Russia, Spain and United Kingdom.
  • 3.In the Middle East and Africa (MEA) region growth forecasts are provided for Algeria, Bahrain, Cote d'Ivoire (Ivory Coast), Egypt, Jordan, Kenya, Kuwait, Lebanon, Morocco, Saudi Arabia,
  • 4.Senegal, South Africa, Tunisia, Turkey and UAE.
  • 5.In the Latin America region growth forecasts are provided for Bolivia, Brazil, Costa Rica, Chile, Colombia, Dominican Republic, Ecuador, Mexico, Paraguay, Peru and Uruguay.
  • 6.In the North America region growth forecasts are provided for Canada and USA.

image3

This report also covers therapy-wise forecast for 15 key therapy areas (Antianemic, Anticoagulant, Antidiabetics, Antifibrinolytic, Antihyperlipidemic, Antihypertensive, Antirheumatics, Antiviral, Bronchodilators, Dermatological, Immunosuppressants, Multiple Sclerosis (MS), Oncology, Sensory Organ and Vaccine) in global pharmaceuticals market.

Research Methodology

image4

Table of Contents
Product Code: NAV0319001

Table of Contents

1. Executive Summary

  • Scope of the Global Pharmaceuticals Industry Analysis and Trends 2023 Report
  • Research Methodology

2. Introduction of Global Pharmaceuticals Market

  • Key Product Terms Used in Pharmaceuticals Industry
  • Pharmaceuticals
  • Innovative Drugs
  • Orphan Drugs
  • Generic Drugs
  • Commodity Generic Drugs
  • Branded Generic Drugs
  • Biologics
  • Biosimilars
  • Over-the-counter (OTC) Drugs
  • Active Pharmaceutical Ingredients (APIs)
  • Excipients
  • Research and Development (R&D) Phases of Pharmaceuticals Industry
  • Industry-Wise Research and Development (R&D) Investment
  • Phase Wise Research and Development (R&D) Investment in Pharmaceuticals Industry
  • Global Pharmaceuticals Industry Value Chain Analysis

3. Need for Global Pharmaceuticals Market

  • Rising & Ageing Global Population
  • Increasing Income Levels of Poor & Middle-Class Families

4. Forecast for Global Pharmaceuticals Market 2023

  • 4.1 Geography-Wise Market Share of Global Pharmaceuticals Market in 2017
  • 4.2 Geography-Wise CAGR Growth Forecast for Global Pharmaceuticals Market 2018-2023
  • 4.3 Forecast for Global Pharmaceuticals Market 2018-2023
  • 4.4 Geography-Wise Market Share of Global Pharmaceuticals Market in 2023
  • 4.5 Forecast for Asia Pacific Pharmaceuticals Market 2018-2023
    • 4.5.1 Forecast for Australia Pharmaceuticals Market 2018-2023
    • 4.5.2 Forecast for China Pharmaceuticals Market 2018-2023
    • 4.5.3 Forecast for India Pharmaceuticals Market 2018-2023
    • 4.5.4 Forecast for Japan Pharmaceuticals Market 2018-2023
    • 4.5.5 Forecast for South Korea Pharmaceuticals Market 2018-2023
    • 4.5.6 Forecast for Rest of Asia Pacific Pharmaceuticals Market 2018-2023
  • 4.6 Forecast for Europe Pharmaceuticals Market 2018-2023
    • 4.6.1 Forecast for France Pharmaceuticals Market 2018-2023
    • 4.6.2 Forecast for Germany Pharmaceuticals Market 2018-2023
    • 4.6.3 Forecast for Italy Pharmaceuticals Market 2018-2023
    • 4.6.4 Forecast for Russia Pharmaceuticals Market 2018-2023
    • 4.6.5 Forecast for Spain Pharmaceuticals Market 2018-2023
    • 4.6.6 Forecast for United Kingdom Pharmaceuticals Market 2018-2023
    • 4.6.7 Forecast for Rest of Europe Pharmaceuticals Market 2018-2023
  • 4.7 Forecast for Middle East and Africa (MEA) Pharmaceuticals Market 2018-2023
    • 4.7.1 Forecast for Algeria Pharmaceuticals Market 2018-2023
    • 4.7.2 Forecast for Bahrain Pharmaceuticals Market 2018-2023
    • 4.7.3 Forecast for Cote d'Ivoire (Ivory Coast) Pharmaceuticals Market 2018-2023
    • 4.7.4 Forecast for Egypt Pharmaceuticals Market 2018-2023
    • 4.7.5 Forecast for Jordan Pharmaceuticals Market 2018-2023
    • 4.7.6 Forecast for Kenya Pharmaceuticals Market 2018-2023
    • 4.7.7 Forecast for Kuwait Pharmaceuticals Market 2018-2023
    • 4.7.8 Forecast for Lebanon Pharmaceuticals Market 2018-2023
    • 4.7.9 Forecast for Morocco Pharmaceuticals Market 2018-2023
    • 4.7.10 Forecast for Saudi Arabia Pharmaceuticals Market 2018-2023
    • 4.7.11 Forecast for Senegal Pharmaceuticals Market 2018-2023
    • 4.7.12 Forecast for South Africa Pharmaceuticals Market 2018-2023
    • 4.7.13 Forecast for Tunisia Pharmaceuticals Market 2018-2023
    • 4.7.14 Forecast for Turkey Pharmaceuticals Market 2018-2023
    • 4.7.15 Forecast for UAE Pharmaceuticals Market 2018-2023
    • 4.7.16 Forecast for Rest of Middle East and Africa (MEA) Pharmaceuticals Market 2018-2023
  • 4.8 Forecast for Latin America Pharmaceuticals Market 2018-2023
    • 4.8.1 Forecast for Bolivia Pharmaceuticals Market 2018-2023
    • 4.8.2 Forecast for Brazil Pharmaceuticals Market 2018-2023
    • 4.8.3 Forecast for Costa Rica Pharmaceuticals Market 2018-2023
    • 4.8.4 Forecast for Chile Pharmaceuticals Market 2018-2023
    • 4.8.5 Forecast for Colombia Pharmaceuticals Market 2018-2023
    • 4.8.6 Forecast for Dominican Republic Pharmaceuticals Market 2018-2023
    • 4.8.7 Forecast for Ecuador Pharmaceuticals Market 2018-2023
    • 4.8.8 Forecast for Mexico Pharmaceuticals Market 2018-2023
    • 4.8.9 Forecast for Paraguay Pharmaceuticals Market 2018-2023
    • 4.8.10 Forecast for Peru Pharmaceuticals Market 2018-2023
    • 4.8.11 Forecast for Uruguay Pharmaceuticals Market 2018-2023
    • 4.8.12 Forecast for Rest of Latin America Pharmaceuticals Market 2018-2023
  • 4.9 Forecast for North America Pharmaceuticals Market 2018-2023
    • 4.9.1 Forecast for Canada Pharmaceuticals Market 2018-2023
    • 4.9.2 Forecast for USA Pharmaceuticals Market 2018-2023
  • 4.10 Therapy-Wise Forecast For Global Pharmaceuticals Market in 2023
    • 4.10.1 Forecast for Global Antianemic Pharmaceuticals Market 2018-2023
    • 4.10.2 Forecast for Global Anticoagulants Pharmaceuticals Market 2018-2023
    • 4.10.3 Forecast for Global Antidiabetics Pharmaceuticals Market 2018-2023
    • 4.10.4 Forecast for Global Antifibrinolytics Pharmaceuticals Market 2018-2023
    • 4.10.5 Forecast for Global Antihyperlipidemics Pharmaceuticals Market 2018-2023
    • 4.10.6 Forecast for Global Antihypertensive Pharmaceuticals Market 2018-2023
    • 4.10.7 Forecast for Global Antirheumatics Pharmaceuticals Market 2018-2023
    • 4.10.8 Forecast for Global Anti-Virals Pharmaceuticals Market 2018-2023
    • 4.10.9 Forecast for Global Bronchodilators Pharmaceuticals Market 2018-2023
    • 4.10.10 Forecast for Global Dermatologicals Pharmaceuticals Market 2018-2023
    • 4.10.11 Forecast for Global Immunosuppressants Pharmaceuticals Market 2018-2023
    • 4.10.12 Forecast for Global Multiple Sclerosis (MS) Pharmaceuticals Market 2018-2023
    • 4.10.13 Forecast for Global Oncology Pharmaceuticals Market 2018-2023
    • 4.10.14 Forecast for Global Sensory Organs Pharmaceuticals Market 2018-2023
    • 4.10.15 Forecast for Global Vaccines Pharmaceuticals Market 2018-2023
    • 4.10.16 Forecast for Global Rest of Therapy Areas Pharmaceuticals Market 2018-2023

5. Growth Drivers and Inhibitors for Global Pharmaceuticals Market

6. Risks Associated with Global Pharmaceuticals Market

  • 6.1 Risk of Patent Expiry and Loss of Intellectual Property Protection
  • 6.2 Risk of Commercial Success of New Products
  • 6.3 Risk of Failed Research and Development Effort
  • 6.4 Risk of Drug Price Controls
  • 6.5 Risk of Failure to Comply with New Laws and Regulations
  • 6.6 Risk of Quality Control During Complex Manufacturing Process
  • 6.7 Risk of Cyber-Attacks and Data Breach
  • 6.8 Risk of Volatile Currency Exchange Rates and Interest Rates
  • 6.9 Risk of Unstable Global Political and Economic Conditions

7. Industry Associations Related to Global Pharmaceuticals Market

  • 7.1 European Federation of Pharmaceutical Industries and Associations (EFPIA)
  • 7.2 International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
  • 7.3 Pharmaceutical Research and Manufacturers of America (PhRMA)
  • 7.4 Association of the British Pharmaceutical Industry (ABPI)
  • 7.5 Japan Pharmaceutical Manufacturers Association (JPMA)
  • 7.6 Indian Drug Manufacturers' Association (IDMA)

8. Profile of Key Players in Global Pharmaceuticals Market

  • 8.1 Pfizer Inc.
  • 8.1.1 Company Profile
  • 8.1.2 Pfizer Inc. in Global Pharmaceuticals Manufacturing Value Chain
  • 8.1.3 Pfizer Inc.: Financial Performance
    • 8.1.3.1 Pfizer Inc.: Overall Revenue FY 2013-FY 2019 (in USD billion)
    • 8.1.3.2 Pfizer Inc.: Geography-Wise Revenue FY 2018 (in USD billion)
    • 8.1.3.3 Pfizer Inc.: Therapy Area-Wise Revenue FY 2018 (in USD billion)
  • 8.1.4 Pfizer Inc.: Business Strategy
    • 8.1.4.1 Product Level Strategy
  • 8.1.5 SWOT Analysis of Pfizer Inc.
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats
  • 8.2 Novartis International AG
  • 8.2.1 Company Profile
  • 8.2.2 Novartis AG in Global Pharmaceuticals Manufacturing Value Chain
  • 8.2.3 Novartis AG: Financial Performance
    • 8.2.3.1 Novartis AG: Overall Revenue FY 2013-FY 2019 (in USD billion)
    • 8.2.3.2 Novartis AG: Geography-Wise Revenue FY 2018 (in USD billion)
    • 8.2.3.3 Novartis AG: Therapy Area-Wise Revenue FY 2018 (in USD billion)
  • 8.2.4 Novartis AG: Business Strategy
  • 8.2.5 SWOT Analysis of Novartis International AG
    • Strengths
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats
  • 8.3 Johnson & Johnson
  • 8.3.1 Company Profile
  • 8.3.2 Johnson & Johnson in Global Pharmaceuticals Manufacturing Value Chain
  • 8.3.3 Johnson & Johnson Financial Performance
    • 8.3.3.1 Johnson & Johnson: Overall Revenue FY 2013-FY 2019 (in USD billion)
    • 8.3.3.2 Johnson & Johnson: Division-Wise Revenue FY 2018 (in USD billion)
    • 8.3.3.3 Johnson & Johnson: Geography-Wise Revenue FY 2018 (in USD billion)
    • 8.3.3.4 Johnson & Johnson: Therapy Area-Wise Revenue FY 2018 (in USD billion)
  • 8.3.4 Johnson & Johnson: Business Strategy
    • 8.3.4.1 Product Level Business Strategy
  • 8.3.5 Johnson & Johnson's Pharmaceutical Division Growth Drivers
  • 8.3.6 SWOT Analysis of Johnson & Johnson
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats
  • 8.4 GlaxoSmithKline PLC
  • 8.4.1 Company Profile
  • 8.4.2 GlaxoSmithKline Plc in Global Pharmaceuticals Manufacturing Value Chain
  • 8.4.3 GlaxoSmithKline Plc: Financial Performance
    • 8.4.3.1 GlaxoSmithKline Plc: Overall Revenue FY 2013-FY 2019 (in USD billion)
    • 8.4.3.2 GlaxoSmithKline Plc: Division-Wise Revenue FY 2018 (in USD billion)
    • 8.4.3.3 GlaxoSmithKline Plc: Geography-Wise Revenue FY 2018 (in USD billion)
    • 8.4.3.4 GlaxoSmithKline Plc: Therapy Area-Wise Revenue FY 2018 (in USD billion)
  • 8.4.4 GlaxoSmithKline Plc: Business Strategy
    • 8.4.4.1 Product Level Strategy
  • 8.4.5 SWOT Analysis of GlaxoSmithKline Plc
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats
  • 8.5 Roche Holding AG
  • 8.5.1 Company Profile
  • 8.5.2 Roche Holding AG in Global Pharmaceuticals Manufacturing Value Chain
  • 8.5.3 Roche Holding AG: Financial Performance
    • 8.5.3.1 Roche Holding AG: Overall Revenue FY 2013-FY 2019 (in CHF billion)
    • 8.5.3.2 Roche Holding AG: Geography-Wise Revenue FY 2018 (in CHF billion)
    • 8.5.3.3 Roche Holding AG: Division-Wise Revenue FY 2018 (in CHF billion)
    • 8.5.3.4 Roche Holding AG: Therapy Area-Wise Pharmaceuticals Revenue FY 2018 (in CHF billion)
    • 8.5.3.5 Roche Holding AG: Segment-Wise Diagnostics Revenue FY 2018 (in CHF billion)
  • 8.5.4 Roche Holding AG: Business Strategy
    • 8.5.4.1 Product Level Strategy
  • 8.5.5 SWOT Analysis of Roche Holding AG
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats
  • 8.6 Merck & Co. Inc.
  • 8.6.1 Company Profile
  • 8.6.2 Merck & Co. Inc. in Global Pharmaceuticals Manufacturing Value Chain
  • 8.6.3 Merck & Co. Inc.: Financial Performance
    • 8.6.3.1 Merck & Co. Inc.: Overall Revenue FY 2013-FY 2019 (in USD billion)
    • 8.6.3.2 Merck & Co. Inc.: Division-Wise Revenue FY 2018 (in USD billion)
    • 8.6.3.3 Merck & Co. Inc.: Geography-Wise Revenue FY 2018 (in USD billion)
    • 8.6.3.4 Merck & Co. Inc.: Therapy Area-Wise Revenue FY 2018 (in USD billion)
  • 8.6.4 Business Strategy of Merck & Co. Inc.
    • 8.6.4.1 Product Level Strategy
  • 8.6.5 SWOT Analysis of Merck & Co. Inc.
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats
  • 8.7 Sanofi S.A.
  • 8.7.1 Company Profile
  • 8.7.2 Sanofi S.A. in Global Pharmaceuticals Manufacturing Value Chain
  • 8.7.3 Sanofi S.A.: Financial Performance (in Euro millions)
    • 8.7.3.1 Sanofi S.A.: Geography-Wise Revenue (in Euro millions)
  • 8.7.4 Sanofi S.A.: Business Strategy
    • 8.7.4.1 Sanofi S.A. Revenue by Global Business Units (GBU's)
    • 8.7.4.2 Sanofi S.A. Revenue by Global Franchise
  • 8.7.5 SWOT Analysis of Sanofi S.A.
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats
  • 8.7.6 Sanofi's TOP 10 Blockbusters Drugs Revenue in FY 2018 (in Euro millions)
  • 8.8 AbbVie Inc.
  • 8.8.1 Company Profile
  • 8.8.2 AbbVie Inc. in Global Pharmaceuticals Manufacturing Value Chain
  • 8.8.3 AbbVie Inc.: Financial Performance
    • 8.8.3.1 AbbVie Inc.: Overall Revenue FY 2013-FY 2019 (in USD billion)
    • 8.8.3.2 AbbVie Inc.: Geography-Wise Revenue FY 2018 (in USD billion)
    • 8.8.3.3 AbbVie Inc.: Therapy Area-Wise Revenue FY 2018 (in USD billion)
  • 8.8.4 AbbVie Inc.: Business Strategy
    • 8.8.4.1 Product Level Strategy
  • 8.8.5 SWOT Analysis of AbbVie Inc.
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats
  • 8.9 Gilead Sciences Inc.
  • 8.9.1 Company Profile
  • 8.9.2 Gilead Sciences, Inc. in Global Pharmaceuticals Manufacturing Value Chain
  • 8.9.3 Gilead Sciences, Inc.: Financial Performance
  • 8.9.4 Gilead Sciences, Inc.: Geography wise Performance
  • 8.9.5 Gilead Sciences, Inc.: Business Strategy
  • 8.9.6 SWOT Analysis of Gilead Sciences, Inc.
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats
  • 8.10 Bayer AG
  • 8.10.1 Company Profile
  • 8.10.2 Bayer in Global Pharmaceuticals Manufacturing Value Chain
  • 8.10.3 Bayer: Financial Performance
    • 8.10.3.1 Bayer: Overall Revenue FY 2013-FY 2019 (in Euro billion)
    • 8.10.3.2 Bayer: Division-Wise Revenue FY 2018 (in Euro billion)
    • 8.10.3.3 Bayer: Geography-Wise Revenue FY 2018 (in Euro billion)
    • 8.10.3.4 Bayer: Best Selling Pharmaceutical Products Revenue FY 2018 (in Euro billion)
    • 8.10.3.5 Bayer: Best Selling Consumer Health Products Revenue FY 2018 (in Euro billion)
    • 8.10.3.6 Bayer: Crop Science Segment-Wise Revenue FY 2018 (in Euro billion)
    • 8.10.3.7 Bayer: Best Selling Animal Health Products Revenue FY 2018 (in Euro billion)
  • 8.10.4 Bayer AG: Business Strategy
    • 8.10.4.1 Product Level Strategy
  • 8.10.5 SWOT Analysis of Bayer AG
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats

9. Competitive Landscape in Global Pharmaceuticals Market

  • 9.1 Competitive Landscape Among Top 10 Pharmaceuticals Companies by Overall Revenue
  • 9.2 Competitive Landscape Among Top 10 Pharmaceuticals Companies by Global Pharmaceuticals Revenue
  • 9.3 Competitive Landscape Among Top 10 Pharmaceuticals Companies by United States Pharmaceuticals Revenue
  • 9.4 Competitive Landscape Among Top 10 Pharmaceuticals Companies by Research and Development (R&D) Expenditure
  • 9.5 Competitive Landscape Among Top 10 Pharmaceuticals Companies by Earning Per Share (EPS)
  • 9.6 Competitive Landscape Among Top 10 Pharmaceuticals Companies by Earnings Before Interest, Tax, Depreciation and Amortization (EBITDA)
  • 9.7 Competitive Landscape Among Top 10 Pharmaceuticals Companies by Overall Revenue Forecast
  • 9.8 Competitive Landscape Among Top 10 Pharmaceuticals Companies by Top 3 Product Revenues

10. Analysis of Global Pharmaceuticals Market

  • 10.1 Porter's Five Forces Analysis of Global Pharmaceuticals Market
  • 10.2 SWOT Analysis of Global Pharmaceuticals Market
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats

11. Current and Future Trends in Global Pharmaceuticals Market

  • List of Exhibits
  • Notes
  • Company Information

List of Exhibits

  • Exhibit 2.1 Research and Development Phases of Pharmaceuticals Industry
  • Exhibit 2.2 Industry-Wise Research and Development Investment in Comparison to Net Sales (in %)
  • Exhibit 2.3 Phase-Wise Research and Development Investment in Pharmaceuticals Industry
  • Exhibit 2.4 Global Pharmaceuticals Industry Value Chain Analysis
  • Exhibit 3.1 Country-Wise Population Forecast 2016-2023 (in millions)
  • Exhibit 3.2 Country-Wise Purchasing Power Parity Based Per Capita GDP Forecast 2016-2023 (in USD)
  • Exhibit 4.1 Geography-Wise Global Pharmaceuticals Market in 2017 (in USD billion)
  • Exhibit 4.2 Geography-Wise CAGR Growth Rate of Global Pharmaceuticals Market from 2018-2023 (in %)
  • Exhibit 4.3 Forecast for Global Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.4 Geography-Wise Global Pharmaceuticals Market in 2023 (in USD billion)
  • Exhibit 4.5 Forecast for Asia Pacific Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.6 Country-wise Market Share in Asia Pacific Pharmaceuticals Market in 2017 (in %)
  • Exhibit 4.7 Country-wise CAGR Growth Forecast for Asia Pacific Pharmaceuticals Market 2018-2023 (in %)
  • Exhibit 4.8 Population Forecast for Australia 2016-2023 (in millions)
  • Exhibit 4.9 Australia Pharmaceuticals Market Analysis
  • Exhibit 4.10 Forecast for Australia Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.11 Population Forecast for China 2016-2023 (in millions)
  • Exhibit 4.12 China Pharmaceuticals Market Analysis
  • Exhibit 4.13 Forecast for China Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.14 Population Forecast for India 2016-2023 (in millions)
  • Exhibit 4.15 India Pharmaceuticals Market Analysis
  • Exhibit 4.16 Forecast for India Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.17 Population Forecast for Japan 2016-2023 (in millions)
  • Exhibit 4.18 Japan Pharmaceuticals Market Analysis
  • Exhibit 4.19 Forecast for Japan Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.20 Population Forecast for South Korea 2016-2023 (in millions)
  • Exhibit 4.21 South Korea Pharmaceuticals Market Analysis
  • Exhibit 4.22 Forecast for South Korea Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.23 Forecast for Rest of Asia Pacific Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.24 Forecast for Europe Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.25 Country-wise Market Share in Europe Pharmaceuticals Market in 2017 (in %)
  • Exhibit 4.26 Country-wise CAGR Growth Forecast for Europe Pharmaceuticals Market 2018-2023 (in %)
  • Exhibit 4.27 Population Forecast for France 2016-2023 (in millions)
  • Exhibit 4.28 France Pharmaceuticals Market Analysis
  • Exhibit 4.29 Forecast for France Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.30 Population Forecast for Germany 2016-2023 (in millions)
  • Exhibit 4.31 Germany Pharmaceuticals Market Analysis
  • Exhibit 4.32 Forecast for Germany Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.33 Population Forecast for Italy 2016-2023 (in millions)
  • Exhibit 4.34 Italy Pharmaceuticals Market Analysis
  • Exhibit 4.35 Forecast for Italy Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.36 Population Forecast for Russia 2016-2023 (in millions)
  • Exhibit 4.37 Russia Pharmaceuticals Market Analysis
  • Exhibit 4.38 Forecast for Russia Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.39 Population Forecast for Spain 2016-2023 (in millions)
  • Exhibit 4.40 Spain Pharmaceuticals Market Analysis
  • Exhibit 4.41 Forecast for Spain Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.42 Population Forecast for United Kingdom 2016-2023 (in millions)
  • Exhibit 4.43 United Kingdom Pharmaceuticals Market Analysis
  • Exhibit 4.44 Forecast for United Kingdom Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.45 Forecast for Rest of Europe Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.46 Forecast for Middle East and Africa (MEA) Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.47 Country-wise Market Share in Middle East and Africa (MEA) Pharmaceuticals Market in 2017 (in %)
  • Exhibit 4.48 Country-wise CAGR Growth Forecast for Middle East and Africa (MEA) Pharmaceuticals Market 2018-2023 (in %)
  • Exhibit 4.49 Population Forecast for Algeria 2016-2023 (in millions)
  • Exhibit 4.50 Forecast for Algeria Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.51 Population Forecast for Bahrain 2016-2023 (in millions)
  • Exhibit 4.52 Forecast for Bahrain Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.53 Population Forecast for Cote d'Ivoire (Ivory Coast) 2016-2023 (in millions)
  • Exhibit 4.54 Forecast for Cote d'Ivoire (Ivory Coast) Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.55 Population Forecast for Egypt 2016-2023 (in millions)
  • Exhibit 4.56 Forecast for Egypt Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.57 Population Forecast for Jordan 2016-2023 (in millions)
  • Exhibit 4.58 Forecast for Jordan Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.59 Population Forecast for Kenya 2016-2023 (in millions)
  • Exhibit 4.60 Forecast for Kenya Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.61 Population Forecast for Kuwait 2016-2023 (in millions)
  • Exhibit 4.62 Forecast for Kuwait Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.63 Population Forecast for Lebanon 2016-2023 (in millions)
  • Exhibit 4.64 Forecast for Lebanon Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.65 Population Forecast for Morocco 2016-2023 (in millions)
  • Exhibit 4.66 Forecast for Morocco Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.67 Population Forecast for Saudi Arabia 2016-2023 (in millions)
  • Exhibit 4.68 Forecast for Saudi Arabia Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.69 Population Forecast for Senegal 2016-2023 (in millions)
  • Exhibit 4.70 Forecast for Senegal Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.71 Population Forecast for Senegal 2016-2023 (in millions)
  • Exhibit 4.72 South Africa Pharmaceuticals Market Analysis
  • Exhibit 4.73 Forecast for South Africa Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.74 Population Forecast for Tunisia 2016-2023 (in millions)
  • Exhibit 4.75 Forecast for Tunisia Pharmaceuticals Market 2018-2023 (in USD bilExhibit 4.93 Colombia Pharmaceuticals Market Analysislion)
  • Exhibit 4.76 Population Forecast for Turkey 2016-2023 (in millions)
  • Exhibit 4.77 Forecast for Turkey Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.78 Population Forecast for UAE 2016-2023 (in millions)
  • Exhibit 4.79 Forecast for UAE Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.80 Forecast for UAE Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.81 Forecast for Latin America Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.82 Country-wise Market Share in Latin America Pharmaceuticals Market in 2017 (in %)
  • Exhibit 4.83 Country-wise CAGR Growth Forecast for Latin America Pharmaceuticals Market 2018-2023 (in %)
  • Exhibit 4.84 Population Forecast for Bolivia 2016-2023 (in millions)
  • Exhibit 4.85 Forecast for Bolivia Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.86 Population Forecast for Brazil 2016-2023 (in millions)
  • Exhibit 4.87 Brazil Pharmaceuticals Market Analysis
  • Exhibit 4.88 Forecast for Brazil Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.89 Population Forecast for Chile 2016-2023 (in millions)
  • Exhibit 4.90 Chile Pharmaceuticals Market Analysis
  • Exhibit 4.91 Forecast for Chile Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.92 Population Forecast for Colombia 2016-2023 (in millions)
  • Exhibit 4.93 Colombia Pharmaceuticals Market Analysis
  • Exhibit 4.94 Forecast for Colombia Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.95 Population Forecast for Costa Rica 2016-2023 (in millions)
  • Exhibit 4.96 Costa Rica Pharmaceuticals Market Analysis
  • Exhibit 4.97 Forecast for Costa Rica Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.98 Population Forecast for Dominican Republic 2016-2023 (in millions)
  • Exhibit 4.99 Forecast for Dominican Republic Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.100 Population Forecast for Ecuador 2016-2023 (in millions)
  • Exhibit 4.101 Forecast for Ecuador Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.102 Population Forecast for Mexico 2016-2023 (in millions)
  • Exhibit 4.103 Mexico Pharmaceuticals Market Analysis
  • Exhibit 4.104 Forecast for Mexico Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.105 Population Forecast for Paraguay 2016-2023 (in millions)
  • Exhibit 4.106 Forecast for Paraguay Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.107 Population Forecast for Peru 2016-2023 (in millions)
  • Exhibit 4.108 Forecast for Peru Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.109 Population Forecast for Uruguay 2016-2023 (in millions)
  • Exhibit 4.110 Forecast for Uruguay Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.111 Forecast for Rest of Latin America Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.112 Forecast for North America Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.113 Country-wise Market Share in North America Pharmaceuticals Market in 2017 (in %)
  • Exhibit 4.114 Country-wise CAGR Growth Forecast for North America Pharmaceuticals Market 2018-2023 (in %)
  • Exhibit 4.115 Population Forecast for Canada 2016-2023 (in millions)
  • Exhibit 4.116 Canada Pharmaceuticals Market Analysis
  • Exhibit 4.117 Forecast for Canada Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.118 Population Forecast for USA 2016-2023 (in millions)
  • Exhibit 4.119 USA Pharmaceuticals Market Analysis
  • Exhibit 4.120 Forecast for USA Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.121 Therapy Area-wise Market Share in Global Pharmaceuticals Market in 2017 (in %)
  • Exhibit 4.122 Therapy Area-wise CAGR Growth Forecast for Global Pharmaceuticals Market 2018-2023 (in %)
  • Exhibit 4.123 Forecast for Global Antianemic Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.124 Forecast for Global Anticoagulants Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.125 Forecast for Global Antidiabetics Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.126 Forecast for Global Antifibrinolytics Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.127 Forecast for Global Antihyperlipidemics Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.128 Forecast for Global Antihypertensive Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.129 Forecast for Global Antirheumatics Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.130 Forecast for Global Anti-Virals Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.131 Forecast for Global Bronchodilators Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.132 Forecast for Global Dermatologicals Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.133 Forecast for Global Immunosuppressants Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.134 Forecast for Global Multiple Sclerosis (MS) Therapies Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.135 Forecast for Global Oncology Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.136 Forecast for Global Sensory Organs Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.137 Forecast for Global Vaccines Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 4.138 Forecast for Global Rest of Therapy Areas Pharmaceuticals Market 2018-2023 (in USD billion)
  • Exhibit 5.1 Growth Drivers and Inhibitors for Global Pharmaceuticals Market
  • Exhibit 6.1 Country-Wise Drug Price Control Policies in Global Pharmaceuticals Market
  • Exhibit 7.1 Key Information of EFPIA
  • Exhibit 7.2 Contact details of EFPIA
  • Exhibit 7.3 List of EFPIA Members
  • Exhibit 7.4 Key Information of IFPMA
  • Exhibit 7.5 Contact details of IFPMA
  • Exhibit 7.6 List of IFPMA Members
  • Exhibit 7.7 Key Information of PhRMA
  • Exhibit 7.8 Contact details of PhRMA
  • Exhibit 7.9 List of PhRMA Members
  • Exhibit 7.10 Key information of ABPI
  • Exhibit 7.11 Contact details of ABPI
  • Exhibit 7.12 List of ABPI Members
  • Exhibit 7.13 Key Information of JPMA
  • Exhibit 7.13 Key Information of JPMA
  • Exhibit 7.15 List of JPMA Members
  • Exhibit 7.16 Key information of IDMA
  • Exhibit 7.17 Contact details of IDMA
  • Exhibit 8.1 Key Information of Pfizer Inc.
  • Exhibit 8.2 Contact information of Pfizer Inc.
  • Exhibit 8.3 Pfizer Inc. in Pharmaceuticals Manufacturing Value Chain
  • Exhibit 8.4 Revenue of Pfizer Inc. FY 2013- FY 2019 (in USD billion)
  • Exhibit 8.5 Revenue Growth of Pfizer Inc. FY 2014- FY 2019 (in %)
  • Exhibit 8.6 Geography-Wise Revenue of Pfizer Inc. in FY 2018 (in USD billion)
  • Exhibit 8.7 Therapy Area-Wise Revenue of Pfizer Inc. in FY 2018 (in USD billion)
  • Exhibit 8.8 Therapy and Geography Area-Wise Revenue of Pfizer Inc. FY 2018 (in USD billion)j
  • Exhibit 8.9 SWOT Analysis of Pfizer Inc.
  • Exhibit 8.10 Key Information of Novartis AG
  • Exhibit 8.11 Contact Information of Novartis AG
  • Exhibit 8.12 Novartis AG in Pharmaceuticals Manufacturing Value Chain
  • Exhibit 8.13 Revenue of Novartis AG FY 2013- FY 2019 (in USD billion)
  • Exhibit 8.14 Revenue Growth of Novartis AG FY 2014- FY 2019 (in %)
  • Exhibit 8.15 Geography-Wise Revenue of Novartis AG in FY 2018 (in USD billion)
  • Exhibit 8.16 Therapy and Geography Area-Wise Revenue of Novartis AG FY 2018 (in USD million)
  • Exhibit 8.17 Business Division-Wise Revenue of Novartis AG in FY 2018 (in USD million)
  • Exhibit 8.18 Innovative Medicines Division Revenue of Novartis AG FY 2017- FY 2019 (in USD billion)
  • Exhibit 8.19 Sandoz Division Revenue of Novartis AG FY 2017- FY 2019 (in USD billion)
  • Exhibit 8.20 Alcon Division Revenue of Novartis AG FY 2017- FY 2019 (in USD billion)
  • Exhibit 8.21 10+ potential blockbuster launches planned by Novartis AG in the next 2 years
  • Exhibit 8.22 SWOT Analysis of Novartis AG
  • Exhibit 8.23 Key Information of Johnson & Johnson
  • Exhibit 8.24 Contact information of Johnson & Johnson
  • Exhibit 8.25 Johnson & Johnson in Pharmaceuticals Manufacturing Value Chain
  • Exhibit 8.26 Revenue of Johnson & Johnson FY 2013- FY 2019 (in USD billion)
  • Exhibit 8.27 Revenue Growth of Johnson & Johnson FY 2014- FY 2019 (in %)
  • Exhibit 8.28 Division-Wise Revenue of Johnson & Johnson in FY 2018 (in USD billion)
  • Exhibit 8.29 Consumer Division Revenue of Johnson & Johnson FY 2013- FY 2018 (in USD billion)
  • Exhibit 8.30 Pharmaceuticals Division Revenue of Johnson & Johnson FY 2013- FY 2018 (in USD billion)
  • Exhibit 8.31 Medical Devices Division Revenue of Johnson & Johnson FY 2013- FY 2018 (in USD billion)
  • Exhibit 8.32 Geography-Wise Revenue of Johnson & Johnson in FY 2018 (in USD billion)
  • Exhibit 8.33 Therapy Area-Wise Revenue of Johnson & Johnson in FY 2018 (in USD billion)
  • Exhibit 8.34 Therapy and Geography Area-Wise Revenue of Johnson & Johnson FY 2018 (in USD billion)
  • Exhibit 8.35 SWOT Analysis of Johnson & Johnson
  • Exhibit 8.36 Key information of GSK
  • Exhibit 8.37 Contact Information GSK
  • Exhibit 8.38 GlaxoSmithKline Plc in Pharmaceuticals Manufacturing Value Chain
  • Exhibit 8.39 Revenue of GlaxoSmithKline Plc FY 2013- FY 2019 (in USD billion)
  • Exhibit 8.40 Revenue Growth of GlaxoSmithKline Plc FY 2014- FY 2019 (in %)
  • Exhibit 8.41 Division-Wise Revenue of GlaxoSmithKline Plc in FY 2018 (in USD billion)
  • Exhibit 8.42 Pharmaceuticals Division Revenue of GlaxoSmithKline FY 2013- FY 2018 (in USD billion)
  • Exhibit 8.43 Vaccines Division Revenue of GlaxoSmithKline FY 2013- FY 2018 (in USD billion)
  • Exhibit 8.44 Consumer Healthcare Division Revenue of GlaxoSmithKline FY 2013- FY 2018 (in USD billion)
  • Exhibit 8.45 Geography-Wise Revenue of GlaxoSmithKline in FY 2018 (in USD billion)
  • Exhibit 8.46 Therapy Area-Wise Revenue of GlaxoSmithKline in FY 2018 (in USD billion)
  • Exhibit 8.47 Therapy and Geography Area-Wise Revenue of GlaxoSmithKline FY 2018 (in USD billion)
  • Exhibit 8.48 SWOT Analysis of GlaxoSmithKline Plc
  • Exhibit 8.49 Key Information of Roche Holding AG
  • Exhibit 8.50 Contact Information of Roche Holding AG
  • Exhibit 8.51 Roche Holding AG in Global Pharmaceutical Manufacturing Value Chain
  • Exhibit 8.52 Revenue of Roche Holding AG FY 2013- FY 2019 (in CHF billion)
  • Exhibit 8.53 Revenue Growth of Roche Holding AG FY 2014- FY 2019 (in %)
  • Exhibit 8.54 Geography-Wise Revenue of Roche Holding AG in FY 2018 (in CHF billion)
  • Exhibit 8.55 Division-Wise Revenue of Roche Holding AG in FY 2018 (in CHF billion)
  • Exhibit 8.56 Pharmaceuticals Division Revenue of Roche Holding AG FY 2013- FY 2018 (in CHF billion)
  • Exhibit 8.57 County-Wise Pharmaceuticals Division Revenue of Roche Holding AG FY 2018 (in CHF billion)
  • Exhibit 8.58 Diagnostics Division Revenue of Roche Holding AG FY 2013- FY 2018 (in CHF billion)
  • Exhibit 8.59 County-Wise Diagnostics Division Revenue of Roche Holding AG FY 2018 (in CHF billion)
  • Exhibit 8.60 Therapy Area-Wise Revenue of Roche Holding AG in FY 2018 (in CHF billion)
  • Exhibit 8.61 Therapy Area-Wise Pharmaceuticals Revenue of Roche Holding AG FY 2018 (in CHF billion)
  • Exhibit 8.62 Segment-Wise Diagnostics Revenue of Roche Holding AG FY 2018 (in CHF billion)
  • Exhibit 8.63 SWOT Analysis of Roche Holding AG
  • Exhibit 8.64 Roche Holding AG Pharmaceuticals Product Pipeline
  • Exhibit: 8.65 Key Information of Merck & Co.
  • Exhibit: 8.66 Contact Information of Merck & Co.
  • Exhibit 8.67 Merck & Co., Inc. in Global Pharmaceuticals Manufacturing Value Chain
  • Exhibit 8.68 Revenue of Merck & Co., Inc. FY 2013- FY 2019 (in USD billion)
  • Exhibit 8.69 Revenue Growth of Merck & Co., Inc. FY 2014-FY 2019 (in %)
  • Exhibit 8.70 Division-Wise Revenue of Merck & Co., Inc. in FY 2018 (in USD billion)
  • Exhibit 8.71 Pharmaceuticals Division Revenue of Merck & Co., Inc. FY 2013- FY 2018 (in USD billion)
  • Exhibit 8.72 Animal Health Division Revenue of Merck & Co., Inc. FY 2013- FY 2018 (in USD billion)
  • Exhibit 8.73 Geography-Wise Revenue of Merck & Co., Inc. in FY 2018 (in USD billion)
  • Exhibit 8.74 Therapy Area-Wise Revenue of Merck & Co., Inc. in FY 2018 (in USD billion)
  • Exhibit 8.75 Business Division, Therapy Area and Geography Area-Wise Revenue of Merck & Co., Inc. FY 2018 (in USD billion)
  • Exhibit 8.76 SWOT Analysis of Merck & Co., Inc.
  • Exhibit 8.79 Key Information of Sanofi S.A.
  • Exhibit 8.80 Contact Information of Sanofi S.A.
  • Exhibit 8.81 Sanofi S.A. in Global Pharmaceuticals Manufacturing Value Chain
  • Exhibit 8.82 Sanofi S.A. Revenue FY2014-2019 (in Euro billion)
  • Exhibit 8.83 Year-wise Sanofi S.A. Growth 2014-19 (in %)
  • Exhibit 8.84 Geography-wise Sanofi S.A. Revenue Share FY 2018 (in %)
  • Exhibit 8.85 Geography-wise Sanofi S.A. Revenue FY 2017-2018 (in Euro million)
  • Exhibit 8.86 Global Business Units (GBU's)-wise Sanofi S.A. Revenue FY 2018 (in %)
  • Exhibit 8.87 Global Business Units (GBU's)-wise Sanofi S.A. Revenue FY 2017-2018 (in Euro million)
  • Exhibit 8.88 Global Franchise-wise Sanofi S.A. Revenue FY 2018 (in %)
  • Exhibit 8.89 Global Franchise-wise Sanofi S.A. Revenue FY 2017-2018 (in Euro million)
  • Exhibit 8.90 Sanofi S.A. Speciality Care Franchise Revenue FY 2018 (in %)
  • Exhibit 8.91 Sanofi S.A. Speciality Care Franchise Revenue FY 2015-2018 (in Euro million)
  • Exhibit 8.95 Sanofi S.A. Generic Franchise Revenue FY 2015-2018 (in Euro million)
  • Exhibit 8.96 Sanofi S.A. Vaccines Franchise Revenue FY 2015-2018 (in Euro million)
  • Exhibit 8.97 SWOT Analysis of Sanofi S.A.
  • Exhibit 8.98 Top 10 Blockbuster Drug Revenue of Sanofi (in Euro millions)
  • Exhibit 8.99 Key information of AbbVie Inc.
  • Exhibit 8.100 Contact Information of AbbVie. Inc.
  • Exhibit 8.101 AbbVie. Inc. in Global Pharmaceuticals Manufacturing Value Chain
  • Exhibit 8.102 Revenue of AbbVie Inc. FY 2013- FY 2019 (in USD billion)
  • Exhibit 8.103 Revenue Growth of AbbVie Inc. FY 2014-FY 2019 (in %)
  • Exhibit 8.104 Geography-Wise Revenue of AbbVie Inc. in FY 2018 (in USD billion)
  • Exhibit 8.105 Therapy Area-Wise Revenue of AbbVie Inc. in FY 2018 (in USD billion)
  • Exhibit 8.106 Therapy Area and Geography Area-Wise Revenue of AbbVie Inc. FY 2018 (in USD billion)
  • Exhibit 8.107 SWOT Analysis of AbbVie Inc.
  • Exhibit 8.108 Key Information of Gilead Sciences, Inc.
  • Exhibit 8.109 Contact Information of Gilead Sciences, Inc.
  • Exhibit 8.110 Gilead Sciences, Inc. in Global Pharmaceuticals Manufacturing Value Chain
  • Exhibit 8.111 Gilead Sciences, Inc. Revenue 2014-2019 (in USD billion)
  • Exhibit 8.112 Year-wise Gilead Sciences, Inc. Revenue Growth 2014-19 (in %)
  • Exhibit 8.113 Gilead Sciences, Inc. Geography Wise Revenue Share in (%) 2018
  • Exhibit 8.114 Gilead Sciences, Inc. Geography Wise Revenue in USD Billion (2016 - 2018)
  • Exhibit 8.115 Gilead Sciences, Inc. Business Segment Revenue Share 2018
  • Exhibit 8.116 Gilead Sciences, Inc. Segment wise Revenue in USD Billion (2016- 2018)
  • Exhibit 8.117 Gilead Sciences, Inc. Revenue from HIV Product Sales (2016-2018)
  • Exhibit 8.118 Gilead Sciences, Inc. HIV Product Sales by Medicine in USD Million (2018)
  • Exhibit 8.119 Gilead Sciences, Inc. Revenue from HCV Product Sales (2016-2018)
  • Exhibit 8.120 Gilead Sciences, Inc. HCV Product Sales by Medicine in USD Million (2018)
  • Exhibit 8.121 Gilead Sciences, Inc. Revenue from HBV, Cardio, Oncology and Others Product Sales (2016-2018)
  • Exhibit 8.122 Gilead Sciences, Inc. Revenue from HBV, Cardio, Oncology and Others Product Sales by Medicine in USD Million (2018)
  • Exhibit 8.123 Gilead Sciences, Inc. Revenue from Yescarta® Sales (2017-2018)
  • Exhibit 8.124 SWOT Analysis of Gilead Sciences, Inc.
  • Exhibit 8.125 Key Information of Bayer
  • Exhibit 8.126 Contact Information of Bayer
  • Exhibit 8.127 Bayer AG in Pharmaceuticals Manufacturing Value Chain
  • Exhibit 8.128 Revenue of Bayer FY 2013- FY 2019 (in Euro billion)
  • Exhibit 8.129 Revenue Growth of Johnson & Johnson FY 2014- FY 2019 (in %)
  • Exhibit 8.130 Division-Wise Revenue of Bayer in FY 2018 (in USD billion)
  • Exhibit 8.131 Pharmaceuticals Division Revenue of Bayer FY 2013- FY 2018 (in Euro billion)
  • Exhibit 8.132 Consumer Health Division Revenue of Bayer FY 2013- FY 2018 (in Euro billion)
  • Exhibit 8.133 Crop Science Division Revenue of Bayer FY 2013- FY 2018 (in USD billion)
  • Exhibit 8.134 Crop Science Division Revenue of Bayer FY 2013- FY 2018 (in USD billion)
  • Exhibit 8.135 Geography-Wise Revenue of Bayer in FY 2018 (in Euro billion)
  • Exhibit 8.136 Best Selling Pharmaceuticals Product Revenue of Bayer FY 2018 (in Euro billion)
  • Exhibit 8.137 Best Selling Consumer Health Product Revenue of Bayer FY 2018 (in Euro billion)
  • Exhibit 8.138 Crop Science Segment-Wise Revenue of Bayer FY 2018 (in Euro billion)
  • Exhibit 8.139 Best Selling Animal Health Product Revenue of Bayer FY 2018 (in Euro billion)
  • Exhibit 8.140 Bayer's Research and Development Projects (Phase II) as of January 31, 2019
  • Exhibit 8.141 Bayer's Research and Development Projects (Phase III) as of January 31, 2019
  • Exhibit 8.142 Bayer's Main Products Submitted for Approval as of January 31, 2019
  • Exhibit 8.143 SWOT Analysis of Bayer AG
  • Exhibit 9.1 Competitive Landscape Among Top 10 Pharmaceuticals Companies by Overall Revenue for FY2018 (in USD billion)
  • Exhibit 9.2 Competitive Landscape Among Top 10 Pharmaceuticals Companies by Global Pharmaceuticals Revenue for FY2018 (in USD billion)
  • Exhibit 9.3 Competitive Landscape Among Top 10 Pharmaceuticals Companies by United States Pharmaceuticals Revenue for FY2018 (in USD billion)
  • Exhibit 9.4 Competitive Landscape Among Top 10 Pharmaceuticals Companies by Research and Development (R&D) Expenditure for FY2018 (in USD billion)
  • Exhibit 9.5 Competitive Landscape Among Top 10 Pharmaceuticals Companies by Research and Earning Per Share (EPS) and EBITDA for FY2018 (in USD)
  • Exhibit 9.6 Competitive Landscape Among Top 10 Pharmaceuticals Companies by Earnings Before Interest, Tax, Depreciation and Amortization (EBITDA) for FY2018 (in USD billion)
  • Exhibit 9.7 Competitive Landscape Among Top 10 Pharmaceuticals Companies by Overall Revenue Forecast for FY2019 (in USD billion)
  • Exhibit 9.8 Competitive Landscape Among Top 10 Pharmaceuticals Companies by 3 Blockbuster Product Revenue for FY2018 (in USD billion)
  • Exhibit 10.1 Porter's Five Forces Analysis for Global Pharmaceuticals Market
  • Exhibit 10.2 SWOT Analysis for Global Pharmaceuticals Market

Companies Covered

  • 1. Pfizer Inc.
  • 2. Novartis International AG
  • 3. Johnson & Johnson
  • 4. GlaxoSmithKline PLC
  • 5. Roche Holding AG
  • 6. Merck & Co. Inc.
  • 7. Sanofi S.A.
  • 8. AbbVie Inc.
  • 9. Gilead Sciences Inc.
  • 10. Bayer AG
Back to Top